Company intelligence / Profile preview

Fibioseq Medical

Ownership: Private
Development stage: Commercial

Overview

Fibioseq Medical has developed the WristArt Implant, a novel orthopedic device for total wrist joint replacement. The company recently completed its first-in-human surgery as part of an ongoing clinical study. The implant is designed to restore near-natural movement, alleviate pain and swelling, and minimize surgical invasiveness by preserving most carpal bones and avoiding bone fusion. Preclinical studies have been completed; further biocompatibility and bench testing are ongoing alongside initial human trials[2][7].

Therapeutic areas: Rheumatology
Modalities: DeviceOrthopedic implant
Industry: Implantable Medical Devices

Drug pipeline

1 asset

WristArt

Commercial

Indications: Wrist arthritis, Chronic wrist conditions

Partnerships

Israel Innovation Authority (grant funding)

Beyond the preview

Go deeper on Fibioseq Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibioseq Medical.

Explore the full profile